Limits...
Uterine arteriovenous malformation with positive serum beta-human chorionic gonadotropin: Embolization of both uterine arteries and extra-uterine feeding arteries

View Article: PubMed Central - PubMed

ABSTRACT

The incidence of uterine arteriovenous malformation (AVM) is rare. However, it is clinically significant in that it can cause life-threatening vaginal bleeding. We report a case of a large uterine AVM with positive serum beta-human chorionic gonadotropin. A presumptive diagnosis was made; a uterine AVM accompanied by, early pregnancy or retained product of conception. Because this uterine AVM was extensive, transcatheter arterial embolization of both uterine arteries and extra-uterine feeding arteries was performed. Three months after undergoing transcatheter arterial embolization, complete resolution of the uterine AVM was confirmed without major complication.

No MeSH data available.


Related in: MedlinePlus

Three months after undergoing transcatheter arterial embolization, follow-up transvaginal ultrasonography confirmed complete resolution of the uterine arteriovenous malformation.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC5120079&req=5

Figure 2: Three months after undergoing transcatheter arterial embolization, follow-up transvaginal ultrasonography confirmed complete resolution of the uterine arteriovenous malformation.

Mentions: After TAE, there were no procedure-related major complications and no further vaginal bleeding occurred. Regular follow-up transvaginal US revealed that the lesion had been gradually shrinking. Three months after undergoing TAE, complete resolution of the uterine AVM was finally confirmed: the uterus and both ovaries were normal (Fig. 2). One month post-TAE, the serum β-hCG became negative, and normal menstrual cycles resumed.


Uterine arteriovenous malformation with positive serum beta-human chorionic gonadotropin: Embolization of both uterine arteries and extra-uterine feeding arteries
Three months after undergoing transcatheter arterial embolization, follow-up transvaginal ultrasonography confirmed complete resolution of the uterine arteriovenous malformation.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC5120079&req=5

Figure 2: Three months after undergoing transcatheter arterial embolization, follow-up transvaginal ultrasonography confirmed complete resolution of the uterine arteriovenous malformation.
Mentions: After TAE, there were no procedure-related major complications and no further vaginal bleeding occurred. Regular follow-up transvaginal US revealed that the lesion had been gradually shrinking. Three months after undergoing TAE, complete resolution of the uterine AVM was finally confirmed: the uterus and both ovaries were normal (Fig. 2). One month post-TAE, the serum β-hCG became negative, and normal menstrual cycles resumed.

View Article: PubMed Central - PubMed

ABSTRACT

The incidence of uterine arteriovenous malformation (AVM) is rare. However, it is clinically significant in that it can cause life-threatening vaginal bleeding. We report a case of a large uterine AVM with positive serum beta-human chorionic gonadotropin. A presumptive diagnosis was made; a uterine AVM accompanied by, early pregnancy or retained product of conception. Because this uterine AVM was extensive, transcatheter arterial embolization of both uterine arteries and extra-uterine feeding arteries was performed. Three months after undergoing transcatheter arterial embolization, complete resolution of the uterine AVM was confirmed without major complication.

No MeSH data available.


Related in: MedlinePlus